Syringe News and Research

RSS

Disability tax credit benefits Canadians with diabetes

Some Canadians who use insulin to manage their diabetes may be eligible for a federal tax credit worth up to $1,055 when they file their 2005 tax returns next year, the Canadian Diabetes Association announced recently.

12 Apr 2005

FDA approves first cranial dural sealant

Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.

7 Apr 2005

High-rise homes have the highest levels of cockroach allergens

Roaches like to live high in the sky in places like Chicago, New York City and the Bronx, according to a recent study in the Journal of Allergy and Clinical Immunology. The study, conducted by an allergist affiliated with Children's Medical Center Dallas, found high-rise homes in Northeastern cities had the highest levels of cockroach allergens -- leading to a higher incidence of asthmatic episodes.

30 Mar 2005

MicroJet injector for painless injections

Parents know all too well the pain experienced by their children - and themselves - when the time comes for immunizations at the doctor's office.

21 Mar 2005

Medical supervision for illicit drug injections could reduce syringe sharing

Facilities that provide medical supervision for illicit drug injections could reduce syringe sharing among users, concludes a Canadian study published online by The Lancet.

21 Mar 2005

Study examines consequences of Thailand's "War on Drugs"

Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand’s aggressive war on illicit drugs and the war’s impact on injection drug users.

9 Mar 2005

Risky injection behaviors are established at the onset of injection drug use

The circumstances surrounding the first injection experience of young injection drug users are significantly linked to future injection behavior, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions.

7 Mar 2005

28 percent of injecting drug users acquired their needles from safe sources

Nearly half of injection drug users disposed of their used syringes safely, yet only 28 percent acquired their needles from safe sources, according to a study of injection drug users in Baltimore, Md., conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

27 Feb 2005

Lack of collagen increases likelihood of osteoarthritis

Duke University Medical Center researchers have found that joints whose cartilage lacks a specific type of collagen will develop osteoarthritis – the so-called "wear-and-tear" form of the disease – at a greatly accelerated rate.

20 Feb 2005

Serono announces the availability of Saizen for adult growth hormone deficiency

Serono announced today the availability of Saizen [somatropin (rDNA origin) for injection] for use in the treatment of patients with adult growth hormone deficiency (AGHD), following its FDA approval.

10 Jan 2005

New technologies boost immunisation rates, safety

As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.

6 Dec 2004

Medication errors in sick children might be substantially higher than previously estimated

Medication errors are common in paediatric emergency departments, but the incidence of errors during paediatric resuscitation has not been fully investigated.

3 Dec 2004

Analysis of safety syringe market

One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.

2 Nov 2004

Asia must tackle HIV in injecting drug users

Asian countries must adopt strategies to slow the spread of HIV among injecting drug users, urge researchers in this week's BMJ.

23 Sep 2004

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

14 Sep 2004

Horrifying research into Britain's injecting drug users

Horrifying research out today in the Journal of Epidemiology and Community Health, suggest that one in 50 and one in 80 adults between the ages of 15 and 44 in London, Liverpool, and Brighton is an injecting drug user. And users are more likely to die of their habit in Brighton, finds the study.

12 Aug 2004

New twist to the 2001 anthrax attacks in the U.S.

In a new twist to the 2001 anthrax attacks in the U.S., the Federal Bureau of Investigation is searching 2 homes in new York and New Jersey which may be related to the attacks.

5 Aug 2004

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

A team of researchers led by The Burnham Institute’s Robert C. Liddington has determined the crystal structure of the binding complex between anthrax toxin and one of its host receptors.

8 Jul 2004

Call for special help for young people who inject drugs

Government and health care services are being urged to make special help available for young people who inject drugs, in a bid to minimize drug-related deaths.

16 Jun 2004

New designer steroid discovered in anonymously provided syringe

A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.

14 May 2004